Suchergebnisse - "Chau, Ian"

PubPharm (254)

1

ACORN : Observational Study of Bevacizumab in Combination With First-Line Chemotherapy for Treatment of Metastatic Colorectal Cancer in the UK

enthalten in: Clinical colorectal cancer | 2019

von Khakoo, S. | Chau, I. | Pedley, I. | +10

2

R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trial

enthalten in: Annals of hematology | 2019

von Kühnl, A. | Peckitt, C. | Patel, B. | +13

3

R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trial

enthalten in: Annals of hematology | 2019

von Kühnl, A. | Peckitt, C. | Patel, B. | +13

4

R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trial

enthalten in: Annals of hematology | 2019

von Kühnl, A. | Peckitt, C. | Patel, B. | +13

5

Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment

enthalten in: Journal for immunotherapy of cancer | 2019

von Newey, A. | Griffiths, B. | Michaux, J. | +17

6

Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment

enthalten in: Journal for ImmunoTherapy of Cancer | 2019

von Newey, A. | Griffiths, B. | Michaux, J. | +17

7

Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment

enthalten in: Journal for ImmunoTherapy of Cancer | 2019

von Newey, A. | Griffiths, B. | Michaux, J. | +17

8

Correction to: Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancer

enthalten in: Gastric cancer | 2019

von Chau, I. | Le, D. | Ott, P. | +10

9

Correction to: Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancer

enthalten in: Gastric cancer | 2019

von Chau, I. | Le, D. | Ott, P. | +10

10

Targeting EGFR pathway in metastatic colorectal cancer- tumour heterogeniety and convergent evolution

enthalten in: Critical reviews in oncology/hematology | 2019

von Khan, K. | Valeri, N. | Dearman, C. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[26]